Summary
PDL Biopharma, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
PDL Biopharma, Inc., (PDL or 'the company') manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income-generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. The company is headquartered in Reno, Nevada, the US
Scope
- Detailed information on PDL Biopharma, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of PDL Biopharma, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
PDL Biopharma, Inc.: Company Overview
PDL Biopharma, Inc.: Overview and Key Facts
PDL Biopharma, Inc.: Overview
PDL Biopharma, Inc.: Key Facts
PDL Biopharma, Inc.: Key Employees
PDL Biopharma, Inc.: Key Employee Biographies
PDL Biopharma, Inc.: Major Products and Services
PDL Biopharma, Inc.: Company History
PDL Biopharma, Inc.: Management Statement
PDL Biopharma, Inc.: Locations and Subsidiaries
PDL Biopharma, Inc.: Key Competitors
PDL Biopharma, Inc.: Company Analysis
PDL Biopharma, Inc.: Business Description
PDL Biopharma, Inc.: SWOT Analysis
PDL Biopharma, Inc.: SWOT Overview
PDL Biopharma, Inc.: Strengths
PDL Biopharma, Inc.: Weaknesses
PDL Biopharma, Inc.: Opportunities
PDL Biopharma, Inc.: Threats
PDL Biopharma, Inc.: Corporate Financial Deals Activity
PDL Biopharma, Inc.: Financial Deals Overview
PDL Biopharma, Inc.: Targets and Partners
PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
PDL Biopharma, Inc.: Advisors
PDL Biopharma, Inc.: Top Financial Advisors
PDL Biopharma, Inc.: Mergers and Acquisitions
PDL Biopharma, Inc.: Corporate Venturing
PDL Biopharma, Inc.: Divestments
PDL Biopharma, Inc.: Recent Developments
PDL Biopharma, Inc.: News and Events Summary
PDL Biopharma, Inc.: Business Expansion
PDL Biopharma, Inc.: Contracts
PDL Biopharma, Inc.: Corporate Governance
PDL Biopharma, Inc.: Financial Deals
PDL Biopharma, Inc.: Financial Performance
PDL Biopharma, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Company History
Table 4: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 5: PDL Biopharma, Inc.: Key Competitors
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 7: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: PDL Biopharma, Inc.: Targets and Partners
Table 9: PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
Table 10: PDL Biopharma, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 12: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 13: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 14: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 15: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)
Table 16: PDL Biopharma, Inc.: News and Events Summary
Table 17: PDL Biopharma, Inc.: Business Expansion
Table 18: PDL Biopharma, Inc.: Contracts
Table 19: PDL Biopharma, Inc.: Corporate Governance
Table 20: PDL Biopharma, Inc.: Financial Deals
Table 21: PDL Biopharma, Inc.: Financial Performance
Table 22: PDL Biopharma, Inc.: Strategy and Operations
List of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 2: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 4: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 5: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 6: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 7: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)
